# XORTX Therapeutics Inc.: Form 20-F for the period ended Dec 31, 2025

- Company: [XORTX Therapeutics Inc.](/companies/xrtx.md) (CIK 1729214)
- Form: 20-F
- Filed: 2026-03-20
- Accepted by EDGAR: Mar 20, 2026, 21:00 ET
- Period: 2025-12-31
- Accession: 0001104659-26-032775
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1729214/000110465926032775/tmb-20251231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729214/000110465926032775/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729214/000110465926032775/tmb-20251231x20f.htm

Filed Mar 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-032775. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.